[Treatment of platinum-resistant ovarian cancer]

Nihon Rinsho. 2004 Oct:62 Suppl 10:554-9.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives*
  • Cisplatin* / adverse effects
  • Cisplatin* / pharmacokinetics
  • Clinical Trials as Topic
  • DNA Damage / drug effects
  • Docetaxel
  • Drug Resistance, Neoplasm* / genetics
  • Etoposide / administration & dosage
  • Female
  • Gynecologic Surgical Procedures
  • Humans
  • Irinotecan
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Staging
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology
  • Paclitaxel / administration & dosage
  • Taxoids / administration & dosage
  • Treatment Outcome

Substances

  • Taxoids
  • Docetaxel
  • Etoposide
  • Irinotecan
  • Paclitaxel
  • Cisplatin
  • Camptothecin